NRG oncology radiation therapy oncology group 0822: A phase 2 study of preoperative chemoradiation therapy using intensity modulated radiation therapy in combination with capecitabine and oxaliplatin for patients with locally advanced rectal cancer

International Journal of Radiation Oncology Biology Physics

Volumn 93, Issue 1, 2015, Pages 29-36

  Hong, Theodore S ^a   Moughan, Jennifer ^b   Garofalo, Michael C ^c   Bendell, Johanna ^d   Berger, Adam C ^e   Oldenburg, Nicklas B E ^f   Anne, Pramila Rani ^e   Perera, Francisco ^g   Lee, R Jeffrey ^h   Jabbour, Salma K ⁱ   Nowlan, Adam ^j   Denittis, Albert ^k   Crane, Christopher ^l  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NRG ONCOLOGY STATISTICS AND DATA MANAGEMENT CENTER   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d SARAH CANNON RESEARCH INSTITUTE   (United States)

^e THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^f North Main Radiation Oncology   (United States)

^g LONDON REGIONAL CANCER PROGRAM   (Canada)

^h INTERMOUNTAIN MEDICAL CENTER   (United States)

ⁱ RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^j PIEDMONT HOSPITAL   (United States)

^k Main Line Clinical Laboratories   (United States)

^l UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHEMORADIOTHERAPY; CHEMOTHERAPY; DISEASES; ONCOLOGY; SURGERY; TOXICITY;

CONFIDENCE INTERVAL; GASTROINTESTINAL TOXICITIES; INTENSITY-MODULATED RADIATION THERAPY; LOCALLY ADVANCED RECTAL CANCERS; METHODS AND MATERIALS; NEOADJUVANT CHEMORADIATION; PREOPERATIVE CHEMORADIATION; RADIATION THERAPY ONCOLOGY GROUPS;

RADIOTHERAPY;

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; PLATINUM COMPLEX;

ABDOMINAL DISTENSION; ADULT; AGED; ANOREXIA; ARTICLE; CHEMORADIOTHERAPY; CONSTIPATION; DEHYDRATION; DIARRHEA; DISEASE FREE SURVIVAL; DYSPEPSIA; DYSPHAGIA; ENTERITIS; FECES INCONTINENCE; FEMALE; FLATULENCE; FOLLOW UP; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TOXICITY; HEMORRHOID; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA; OVERALL SURVIVAL; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROCTITIS; PROSPECTIVE STUDY; RECTUM CANCER; TASTE DISORDER; VOMITING; ADJUVANT CHEMORADIOTHERAPY; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; DRUG ADMINISTRATION; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PHASE 2 CLINICAL TRIAL; PREOPERATIVE CARE; PROCEDURES; QUALITY OF LIFE; RECTAL NEOPLASMS; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAPECITABINE; CHEMORADIOTHERAPY, ADJUVANT; DEOXYCYTIDINE; DIARRHEA; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; PREOPERATIVE CARE; QUALITY OF LIFE; RADIOTHERAPY, INTENSITY-MODULATED; RECTAL NEOPLASMS; SURVIVAL RATE;

EID: 84939469155     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2015.05.005     Document Type: Article

References (24)

1. C. Aschele, L. Cionini, S. Lonardi, and et al. Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: Pathologic results of the STAR-01 randomized phase III trial J Clin Oncol 29 2011 2773 2780
2. J.P. Gerard, D. Azria, S. Gourgou-Bourgade, and et al. Comparison of two neoadjuvannt chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405 PRODIGE 2 J Clin Oncol 28 2010 1638 1644
3. M.J. O'Connell, L.H. Colangelo, R.W. Beart, and et al. Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: Surgical end points from National Surgical Adjuvant Breast and Bowel Trial R-05 J Clin Oncol 32 2014 1927 1934
4. S.J. Wong, K. Winter, N.J. Meropol, and et al. Radiation Therapy Oncology Group 0247: A randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer Int J Radiat Oncol Biol Phys 82 2012 1367 1375
5. L.A. Kachnic, K. Winter, R.J. Myerson, and et al. RTOG 0529: A phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal Int J Radiat Oncol Biol Phys 86 2013 27 33
6. J.M. Samuelian, M.D. Callister, J.B. Ashman, and et al. Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer Int J Radiat Oncol Biol Phys 82 2012 1981 1987
7. A. Parekh, M.T. Truong, I. Pashtan, and et al. Acute gastrointestinal toxicity and tumor response with preoperative intensity modulated radiation therapy for rectal cancer Gastrointest Cancer Res 6 2013 137 143
8. R.J. Myerson, M.C. Garofalo, I. El Naqa, and et al. Elective clinical target volumes for conformal therapy in anorectal cancer: A Radiation Therapy Oncology Group consensus panel contouring atlas Int J Radiat Oncol Biol Phys 74 2009 824 830
9. T. Fleming One-sample multiple testing procedure for phase II clinical trials Biometrics 38 1982 143 151
10. E.L. Kaplan, and P. Meier Nonparameteric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
11. J.D. Kalbfleish The statistical analysis of failure time data 1980 John Wiley & Sons New York 167 169
12. K.L. Baglan, R.C. Frazier, D. Yan, and et al. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation for rectal cancer Int J Radiat Oncol Biol Phys 52 2002 176 183
13. J.M. Robertson, D. Lockman, D. Han, and et al. The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer Int J Radiat Oncol Biol Phys 70 2008 413 418
14. R. Sauer, H. Becker, W. Hohenberger, and et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
15. J.F. Bosset, L. Collete, G. Calais, and et al. Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 2006 1114 1123
16. L.S. Blaszkowsky, D.P. Ryan, J. Szymonifka, and et al. Phase I/II study of neoadjuvant bevacizumab, erlotinib, and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer Ann Oncol 25 2014 121 126
17. M.J. Gallagher, H.D. Brereton, R.A. Rostock, and et al. A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation Int J Radiat Oncol Biol Phys 12 1986 1565 1573
18. B. Emami, J. Lyman, A. Brown, and et al. Tolerance of normal tissue to therapeutic irradiation Int J Radiat Oncol Biol Phys 21 1991 109 122
19. R.C. Chen, H.J. Mamon, M. Ancukiewicz, and et al. Dose-volume effects on patient-reported acute gastrointestinal symptoms during chemoradiation therapy for rectal cancer Int J Radiat Oncol Biol Phys 83 2012 e513 e517
20. R. Banerjee, S. Chakroborty, I. Nygren, and et al. Small bowel dose parameters predicting acute toxicity in rectal cancer patients treated with neoadjuvant chemoradiation: An independent validation study comparing peritoneal space versus small bowel loop contouring techniques Int J Radiat Oncol Biol Phys 85 2013 1225 1231
21. R.C. Chen, H.J. Mamon, Y. Chen, and et al. Patient-reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancer Cancer 116 2010 1379 1386
22. G.M. Freedman, N.J. Meropol, E.R. Digurdson, and et al. Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer Int J Radiat Oncol Biol Phys 67 2007 1389 1393
23. J. Zhu, W. Gu, P. Lian, and et al. A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma Radiat Oncol 8 2013 130 136
24. A. Ballonoff, B. Kavanagh, M. McCarter, and et al. Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: A phase II trial Am J Clin Oncol 31 2008 264 270